Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Indian IOLCP boosts Ibuprofen plant capacity
November 19, 2015 Off

Indian IOLCP boosts Ibuprofen plant capacity

By Dino Mustafić

IOLCP has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen Manufacturing facilities at Barnala with project cost of Rs 24 Crores, and has started the enhanced production from Thursday.

November 19, 2015 Off

(Edited) Dr Reddy’s refutes allegations

By Dino Mustafić

Dr. Reddy’s Laboratories has issued a press release reacting to certain statements that appeared in the certain media on Thursday.

November 18, 2015 Off

Health Canada to review Janssen’s NDS for daratumumab for Multiple Myeloma

By Dino Mustafić

Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.

UK cost watchdog turns down Amgen’s new cholesterol drug
November 18, 2015 Off

UK cost watchdog turns down Amgen’s new cholesterol drug

By Dino Mustafić

Amgen’s new injectable cholesterol drug Repatha has been turned down for use on Britain’s state health service, underscoring a worldwide debate about the value of such pricey medicines.

World Antibiotic Awareness Week; help patients get smart about antibiotic use
November 18, 2015 Off

World Antibiotic Awareness Week; help patients get smart about antibiotic use

By Dino Mustafić

US Food and Drug Administration (FDA) has issued a video in which it suggest to pharmacists how to encourage the appropriate use of antibiotics.

Advanced Oncotherapy disposes of its subsiadiary for £100K
November 18, 2015 Off

Advanced Oncotherapy disposes of its subsiadiary for £100K

By Dino Mustafić

Advanced Oncotherapy has disposed of its subsidiary, Oncotherapy Resources Ltd (ORL), for a total cash consideration of £100,000 to Xstrahl.…

November 18, 2015 Off

FDA grants Breakthrough Therapy designation to Avelumab for treating Merkel cell carcinoma

By Dino Mustafić

  The US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough…

November 18, 2015 Off

Anavex prepares for regulatory filings based on FDA guidance

By Dino Mustafić

Anavex is moving forward with the development program for ANAVEX 2-73 for the treatment of Alzheimer’s disease in a…

AmerisourceBergen in managerial changes. Adoption of proxy access
November 18, 2015 Off

AmerisourceBergen in managerial changes. Adoption of proxy access

By Dino Mustafić

Steven H. Collis, the President and Chief Executive Officer (CEO) of AmerisourceBergen Corporation will succeed Richard C. Gozon as Chairman of the Board

November 18, 2015 Off

Vertex gets EU approval for expanded use of its cystic fibrosis drug Kalydeco

By Dino Mustafić

The European Commission has approved expansion of the indication for Vertex Pharmaceuticals’ Kalydeco, to include children ages 2-5 with cystic fibrosis…

Posts pagination

Previous 1 … 3,582 3,583 3,584 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine